kabutan

C.I. MEDICAL, First Half Ordinary Profit Increases by 2.3 times, Postponed Dividend for This Fiscal Year

Thu Aug 7, 2025 4:30 pm JST Earnings

3540 C.I. MEDICAL CO.,LTD. 【J-GAAP】

Earnings Report

C.I. MEDICAL CO.,LTD. <3540> [TSE Std] announced its financial results after the market closed on August 7th (16:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending December 2025 (January to June) surged 2.3 times that of the same period last year, reaching 2.26 billion yen. However, Progress toward the full-year plan of 4.54 billion yen was 49.8%, almost the same as the five-year average of 50.2%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the July to December period (second half) is expected to expand 38.2% from the same period last year, reaching 2.28 billion yen.

At the same time, In conjunction with a Tender Offer Bid (TOB), the company has decided to forgo the year-end lump-sum dividend of undecided for the current fiscal year.

In the most recent three-month period, from April to June (2Q), the consolidated ordinary profit surged 2.6 times that of the same period last year, reaching 1.45 billion yen. The operating profit margin improved from 4.7% in the same period last year to 6.0%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 22,197 1,768 1,953 1,226 24.5 59.3 Aug 8, 2023 J-GAAP
Jan - Jun, 2024 24,316 983 971 577 11.6 37.0 Aug 13, 2024 J-GAAP
Jan - Jun, 2025 46,133 2,125 2,260 2,467 49.3 49.8 Aug 7, 2025 J-GAAP
YoY +89.7% +116.2% +132.7% +327.6% +327.2%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance 46,550 2,020 2,130 2,400 48.0 － May 13, 2025 J-GAAP
Jan - Jun, 2025 Results 46,133 2,125 2,260 2,467 49.3 0 Aug 7, 2025 J-GAAP
Revision Rate -0.9% +5.2% +6.1% +2.8% +2.8%

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Prev 100,000 4,380 4,540 4,000 80.0 － May 13, 2025 J-GAAP
Dec, 2025 New 100,000 4,380 4,540 4,000 80.0 0 Aug 7, 2025 J-GAAP
Revision Rate 0.0% 0.0% 0.0% 0.0% 0.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 43,177 1,510 1,650 5,689 113.8 12.53 Feb 12, 2025 J-GAAP
Jul - Dec, 2025 Guidance 53,867 2,255 2,280 1,533 30.7 0 Aug 7, 2025 J-GAAP
YoY +24.8% +49.3% +38.2% -73.1% -73.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 45,628 2,989 3,295 2,082 41.7 5.04 Feb 13, 2024 J-GAAP
Dec, 2024 67,493 2,493 2,621 6,266 125.3 12.53 Feb 12, 2025 J-GAAP
Dec, 2025 Guidance 100,000 4,380 4,540 4,000 80.0 0 Aug 7, 2025 J-GAAP
YoY +48.2% +75.7% +73.2% -36.2% -36.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 12,370 576 564 330 6.6 4.7 Aug 13, 2024 J-GAAP
Jul - Sep, 2024 20,932 125 314 4,760 95.2 0.6 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 22,245 1,385 1,336 929 18.6 6.2 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 22,657 708 806 1,367 27.4 3.1 May 13, 2025 J-GAAP
Apr - Jun, 2025 23,476 1,417 1,454 1,100 22.0 6.0 Aug 7, 2025 J-GAAP
YoY +89.8% +146.0% +157.8% +233.3% +232.8%

Related Articles